Neurodegenerative Disease & Therapeutics
We work to identify mechanisms, risk factors, and causes of neurodegenerative diseases using basic and translational multidisciplinary research to develop novel approaches to diagnosis and therapy thus improving clinical outcomes.
In this section
In this section
Grace E. Stutzmann (Beth), PhD
Director, Center for Neurodegenerative Disease and Therapeutics
- Grace E. Stutzmann (Beth) – Center Director
- Early neuronal pathology that occurs prior to the emergence of histopathology and cognitive decline in Alzheimer’s disease.
- Holly Hunsberger
- Unraveling sex differences throughout aging and Alzheimer’s disease with an emphasis on mood disorders.
- Dissecting neural circuitry changes across whole brain networks in Alzheimer’s disease to create targeted therapeutics for men and women.
- Robert Marr
- Use of gene transfer vectors to investigate specific gene functions in the brain as it relates to Alzheimer’s disease.
- Daniel A. Peterson
- Recruitment of adult endogenous stem cells to generate replacement neurons for brain repair.
- Recruitment of adult endogenous stem cells to overcome impaired wound healing characteristic of diabetes.
- Judith A. Potashkin
- Identification of dysregulated molecular pathways that lead to progressive neurodegeneration in Parkinson’s disease and dementias.
- Identification of diagnostic, progression and stratification RNA biomarkers in blood for Parkinson’s disease.